JDRF T1D Fund is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities. The firm was launched in 2016 and is solely focused on T1D investments. The firm looks to provide equity investments in companies developing T1D products. Their portfolio consists of therapeutics, devices, vaccines, and diagnostics.
The firm has invested in fifteen companies, and holds $70 million in assets, and has helped raised over $200 million for their portfolio.
Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells.
Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases.
A biotechnology company developing therapies and personalized diagnostics for celiac disease
Bigfoot Biomedical is a Milpitas, California-based company.
Biolinq, Inc. is a San Diego-based company founded by Joshua Windmiller.
Veralox Therapeutics is a small molecule drug discovery and development firm based in the Frederick Innovative Technology Center, Inc.
Immunomolecular Therapeutics is a biotechnology company.